HKSE:03692 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:03692 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Hansoh Pharmaceutical Group Co's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.29.
The historical rank and industry rank for Hansoh Pharmaceutical Group Co's Dividend Payout Ratio or its related term are showing as below:
During the past 9 years, the highest Dividend Payout Ratio of Hansoh Pharmaceutical Group Co was 0.43. The lowest was 0.14. And the median was 0.22.
As of today (2025-04-20), the Dividend Yield % of Hansoh Pharmaceutical Group Co is 1.55%.
During the past 9 years, the highest Trailing Annual Dividend Yield of Hansoh Pharmaceutical Group Co was 1.55%. The lowest was 0.41%. And the median was 0.69%.
Hansoh Pharmaceutical Group Co's Dividends per Share for the months ended in Jun. 2024 was HK$0.14.
During the past 12 months, Hansoh Pharmaceutical Group Co's average Dividends Per Share Growth Rate was 114.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
The historical data trend for Hansoh Pharmaceutical Group Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co Annual Data | |||||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | ||||||||||
Dividend Payout Ratio | Get a 7-Day Free Trial |
![]() |
- | 0.14 | 0.29 | 0.22 | 0.43 |
Hansoh Pharmaceutical Group Co Semi-Annual Data | ||||||||||||||||
Dec16 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | Dec24 | |
Dividend Payout Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
0.22 | 0.21 | 0.23 | 0.29 | 0.69 |
For the Drug Manufacturers - Specialty & Generic subindustry, Hansoh Pharmaceutical Group Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Hansoh Pharmaceutical Group Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Hansoh Pharmaceutical Group Co's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Hansoh Pharmaceutical Group Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Dividend Payout Ratio | = | Dividends per Share (A: Dec. 2023 ) | / | EPS without NRI (A: Dec. 2023 ) |
= | 0.121 | / | 0.547 | |
= | 0.22 |
Hansoh Pharmaceutical Group Co's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as
Dividend Payout Ratio | = | Dividends per Share (Q: Jun. 2024 ) | / | EPS without NRI (Q: Jun. 2024 ) |
= | 0.142 | / | 0.494 | |
= | 0.29 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hansoh Pharmaceutical Group Co (HKSE:03692) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Apex Medical Company Ltd. | 2101 Beneficial owner | |
Cen Junda | 2307 Founder of a discretionary trust who can infl | |
Cantrust (far East) Limited | 2301 Trustee | |
Jqc Holding Limited | 2201 Interest of corporation controlled by you | |
Jqc International Limited | 2201 Interest of corporation controlled by you | |
Sun Yuan | 2101 Beneficial owner | |
Harmonia Holding Investing (ptc) Limited | 2201 Interest of corporation controlled by you | |
Stellar Infinity Company Ltd. | 2101 Beneficial owner | |
Sunrise Investment Advisors Limited | 2201 Interest of corporation controlled by you | |
Zhong Huijuan | 2307 Founder of a discretionary trust who can infl |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.